Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
PharmafocusNews Register for New Alert
News for July 2005
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Arixtra approved for new blood clot indication
New indication to boost sales..(more)

 New 28-day pack for Cozaar launched
MSD responds to customer demands..(more)

 PR group launched to counter pharma's poor public image
CIPR seeks to create positive pharma image..(more)

 NICE calls for more Alzheimer's evidence to head off row
NICE may be seeking compromise..(more)

 Iressa successor enters phase III
AstraZeneca upbeat about Zactima..(more)

 AstraZeneca invests in novel cholesterol drugs
Plaque busting drug in development..(more)

 Arimidex approved for post-surgery cancer prevention
Arimidex leads UK market..(more)

 NHS tsar calls on clinicians to reassess clinical practice
Efficiency improvements needed..(more)

 'Virtual super surgeries' the future for primary care
NHS Alliance predicts change for priamry care..(more)

 Pfizer pulls out of Daxas collaboration
Altana's shares fall as it looks for another partner..(more)

 ABPI sets up links to clinical trials databases
Pharma companies aim to be more transparent..(more)

 GSK win for Euro RSCG Life MSC
Agency prevails in three-way pitch..(more)

 'Ticking time bomb' will go off as NHS investment slows
Financial expertise needed..(more)

 No more Alton Towers? UK pharma downsizes its hospitality
Pharma companies pre-empt new European rules..(more)

 Lilly buys rights to novel diabetes drug
Japanese company Taisho sells rights..(more)

 People Strategies launch
Company to take care of human element..(more)

 GSK excited about new vaccines
Cervarix leads the way..(more)

 Antidepressants come under FDA review again
Review to take over a year to complete..(more)

 Woolley Pau wins Chiron campaign
Agency to work on European campaign..(more)

 FDA approves first 'ethnic' heart drug
BiDil approved by FDA..(more)

 GSK forms hypertension alliance
GSK joins forces with Vitae..(more)

 FDA approves new HIV drug Aptivus
Boehringer Ingelheim's drug approved..(more)

 New products key to Schering growth
Schering sets out to increase profitability..(more)

 Humira receives two European recommendations
Positive opinion from CHMP ..(more)

 Bright future for new antidepressants
First triple action drugs to hit the market..(more)

 NHS to save £300 million on annual generic drugs bill
Pharmacies to benefit from savings..(more)

 Doctors have no time to mentor nurse prescribers
Patients positive about nurse prescribers..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.